Mike Hollan

Culjat discusses FDA’s new draft framework on PDURS.

The test is the first of its kind and is available over the counter.

Astellas Pharma’s chief people officer and chief ethics & compliance officer discusses the unique ways he’s brought DE&I to the workplace.

Key approval signals progress in addressing immune-mediated inflammatory diseases.

New cardiovascular indication builds on treatment’s fast-growing legacy.

The campaign, More to Parkinson’s, will focus on providing education about Parkinson’s related hallucinations.

Heidi Capozzi previously served as chief people officer for McDonald’s.

According to the company, about one-third of the country is at risk for micronutrient deficiency.

It’s time to see where artificial intelligence is genuinely being utilized in pharma.

Abrams discusses how both new pharma and big pharma are reacting to each other and the current market.

The company worked in partnership with Neurocode.

PicnicHealth’s CEO discusses how AI is making data more useful to the life sciences industry.

The Trinity Life Sciences managing director and head of DE&I strategy discusses recent research on the topic.

The two companies will combine assets to develop a device that make automatic adjustments.

Independence Blue Cross and Jefferson health published a study detailing the impact of such care.

The foundation donated over $1 million to these programs.

The life sciences technology company will be able to offer services to the pharmacies associated with Legacy.

Respondents said logistic reasons kept them from going to the doctor.

The company provided guidance for how people in the storm’s path can prepare ahead of time and ensure they have access to medication.

The team launched from California and rowed to one of the islands of Hawaii.

The PGDx elio plasma focus Dx offers laboratories testing options for situations where samples are hard to obtain.

The app provides users with lifestyle tips and plans based on the lifestyles of people living in regions with the highest lifespans.

Integrated Delivery Networks have impacted everything from drug launches to sales approaches.

The report also details steps that employers are taking to manage the cost of healthcare plans for employees.

The company announced that it will conduct research based on guidance from the agency.

Ouva’s AI-powered technology will be added to AvaSure’s digital platform.

The company plans to develop these treatments using it’s AI-powered platform.

MGI Tech Co. issued a statement detailing the use of its technology in improving the rates of genomic sequencing in South Africa.

An unexpected consequence of the COVID 19 pandemic has been a loss in trust of vaccines. Over the past three flu seasons, there has been a drop in vaccination rates that is alarming experts. Dr. Gregg Sylvester, chief health officer at CSL Seqirus, spoke with Pharmaceutical Executive about the causes of the decline and how important it is to get the rates back to normal.

The partnership will allow both group to expand their operations and provide more solutions to underserved communities.